Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients (original) (raw)

Use of Calcium Channel Blockers in Cardiovascular Risk Reduction

Julio Acosta

American Journal Cardiovascular Drugs, 2010

View PDFchevron_right

Calcium channel blockers: the present and the future

John Pieper

Pharmacotherapy

View PDFchevron_right

Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects

Gianpaolo Reboldi

American journal of hypertension, 2004

View PDFchevron_right

Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study

Alec Walker

Circulation, 1998

View PDFchevron_right

Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case–Control Studies on Italian Hypertensive Elderly

Alfredo Vannacci, Niccolò Lombardi

View PDFchevron_right

Efficacy of Calcium Channel Blocker in the Secondary Prevention of Myocardial Infarction

Shigemasa Tani

Circulation Journal, 2004

View PDFchevron_right

The role of calcium channel blockers in the treatment of hypertension

Luigi Cubeddu

American Heart Journal, 1986

View PDFchevron_right

Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association

Tzung-dau Wang

Hypertension Research, 2011

View PDFchevron_right

Calcium channel blockers and hypertension

Allegra Battistoni

Journal of cardiovascular pharmacology and therapeutics, 2015

View PDFchevron_right

Efficacy and safety of ACT-280778, a dual L- and T-type calcium channel blocker, in patients with mild-to-moderate essential hypertension: results from a phase 2a, randomized, double-blind, placebo- and active-controlled trial (REDUCE–1)

Jasper Dingemanse

View PDFchevron_right

Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension

Jasper Dingemanse

Journal of human hypertension, 2015

View PDFchevron_right

How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension

Elisa Roca

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2017

View PDFchevron_right

Health Outcomes Associated with Calcium Antagonists

Curt Furberg

Current Hypertension Reports, 2001

View PDFchevron_right

Outcome With Calcium Channel Antagonists After Myocardial Infarction: A Community-Based Study

Richard Heller

Journal of the American College of Cardiology, 1998

View PDFchevron_right

Efficacy and Safety of Dual Calcium Channel Blockade for the Treatment of Hypertension: A Meta-Analysis

A. Benjo

2013

View PDFchevron_right

Comparison of the Effect of Calcium Channel Blockers and Non-selective Beta-Blockers on Blood Lipids in Hypertensive Patients

Ghulam Murtaza

View PDFchevron_right

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview

Curt Furberg

British Medical Journal, 1989

View PDFchevron_right

Calcium antagonists and mortality in patients with coronary artery disease: A Cohort study of 11,575 patients*1

Avraham Shotan

Journal of the American College of Cardiology, 1996

View PDFchevron_right

Calcium Channel Blocker Therapy: When a Drug Works, it Works. When it Doesn't, it Doesn't

Robert Schilz

Advances in Pulmonary Hypertension, 2017

View PDFchevron_right

Role of calcium channel blocking agents in the prevention of atherosclerosis

Mark Munger

Cardiovascular Drugs and Therapy, 1995

View PDFchevron_right

Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis

Lecteurs Sablon

View PDFchevron_right

Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Jackson Wright

Hypertension, 2006

View PDFchevron_right

A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease

José Cangiano

JAMA, 2003

View PDFchevron_right

Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension* 1

Milena Henzlova

American journal of …, 2001

View PDFchevron_right

Calcium channel blockers in heart failure: Help or hindrance?

Richard Patten

Journal of Cardiac Failure, 1996

View PDFchevron_right

Calcium Channel Blockers in Heart Failure

Avraham Shotan, Uri Elkayam

Cardiology, 1998

View PDFchevron_right

Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension

Joseph Diamond

American journal of hypertension, 2001

View PDFchevron_right